Attached files

file filename
EX-99.1 - PRESS RELEASE - Cellu Tissue Holdings, Inc.dex991.htm





Washington, D.C. 20549







Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 16, 2009



Cellu Tissue Holdings, Inc.

(Exact name of registrant as specified in its charter)




Delaware   333-118829   06-1346495

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)


1855 Lockeway Drive

Suite 501

Alpharetta, Georgia

(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (678) 393-2651

(Former name or former address, if changed since last report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(b) On October 16, 2009, Scott M. Bell resigned from Cellu Tissue Holdings, Inc.’s (the “Company”) Board of Directors and its audit committee, effective as of such date.


Item 8.01. Other Events

On October 16, 2009, the Company issued a press release announcing that it filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock. A copy of the press release is attached hereto as Exhibit 99.1.


Item 9.01. Financial Statements and Exhibits


99.1 Press release concerning registration statement for initial public offering.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Cellu Tissue Holdings, Inc.


Date: October 16, 2009     By:   /S/    DAVID J. MORRIS        
      Mr. David J. Morris

Senior Vice President, Finance and

Chief Financial Officer